Drugs

, Volume 61, Issue 10, pp 1531–1531 | Cite as

Hypertension in Diabetes Mellitus: Role of β-Blockers

  • Franz H. Messerli
  • Ehud Grossman
Correspondence

Keywords

Diabetes Mellitus Myocardial Infarction Coronary Heart Disease Acute Myocardial Infarction Erectile Dysfunction 

References

  1. 1.
    Dunne F, Kendall MJ, Marin U. β-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role? Drugs 2001; 61: 429–35PubMedCrossRefGoogle Scholar
  2. 2.
    Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992; 304: 405–12CrossRefGoogle Scholar
  3. 3.
    Messerli FH, Grossman E, Goldbourt U. Are β-blockers efficacious as first-line therapy for hypertension in the elderly? JAMA 1998; 279: 1903–7PubMedCrossRefGoogle Scholar
  4. 4.
    UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317: 703–13CrossRefGoogle Scholar
  5. 5.
    Sharma AM, Pischon T, Hardt S, et al. Hypothesis: β-adrenergic receptor blockers and weight gain: a systematic analysis. Hypertension 2001; 37: 250–4PubMedCrossRefGoogle Scholar
  6. 6.
    Gress TW, Nieto PJ, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus: atherosclerosis risk in communities study. N Engl J Med 2000; 342: 905–12PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2001

Authors and Affiliations

  • Franz H. Messerli
    • 1
  • Ehud Grossman
    • 2
  1. 1.Department of Internal Medicine Section on HypertensionOchsner Clinic and Alton Ochsner Medical FoundationNew OrleansUSA
  2. 2.Internal Medicine DThe Chaim Sheba Medical CenterTel-HashomerIsrael

Personalised recommendations